https://pubmed.ncbi.nlm.nih.gov/32513797/

Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle

Here, we demonstrate that the antiparasitic drug suramin inhibits SARS-CoV-2 replication, protecting Vero E6 cells with a 50% effective concentration (EC50) of ∼20 μM, which is well below the maximum attainable level in human serum

https://health.ucsd.edu/news/topics/Suramin-Autism/Pages/default.aspx

Suramin and Autism

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038244/

100 Years of Suramin

SURAMIN AS AN ANTIVIRAL AGENT

It was shown to inhibit both RNA synthesis and replication in chikungunya virus (35)

Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism